Public Aid for Innovation 2026: The Concrete Guide to Financing your Project without Diluting your Capital

Do you have an innovation to develop, but the idea of ”‹”‹selling shares in your company is repulsive to you? You are far from alone. 73% of SMEs are unaware of the non-dilutive financing mechanisms available in 2026, even though the French State is mobilizing nearly 10 billion euros per year to support research and innovation. It is not a shortage of public money that is holding back entrepreneurs: it is the lack of clarity on who has access to what, and how.

From my accounting firm in Paris, I regularly support managers who belatedly discover the existence of financing for which they could have applied six months earlier. Worse still: some submit poorly structured files, miss hidden criteria, or combine aid in a clumsy way and end up with adjustments.

This article offers you a complete and prioritized inventory of the 8 main aids accessible in 2026, with for each: eligibility criteria, actual amounts, deposit schedule, and above all, the fatal errors to avoid.

For whom? Early-stage startups, SMEs with fewer than 2,000 employees carrying out a high-risk technological project.

Amount: Up to €50,000 (capped at €30,000 for the majority of winners), covering 50 to 70% of eligible expenses.

What it finances: Internal and external R&D, market studies, technical feasibility, early prototypes, maximum duration 24 months.

The classic trap: Many managers think that BFT finances production or marketing. However, it finances only the technical and economic validation phase. You cannot use it to craft 1,000 units.

Calendar: Applications open as they arise from Bpifrance regional departments. Instruction time: 1 to 3 months.

For whom? Startups founded less than a year ago, carrying DeepTech projects (technological breakthrough, coming from a public or private laboratory, with strong technological locks).

Amount: Up to €90,000 in grant, covering 50 to 70% of expenses.

What it finances: Scientific maturation, advanced proofs of concept, upstream industrial research work.

Key difference with classic BFT: BFTE accepts higher technological risks. It funds the “deep” in your technology, before you even know if it will sell.

Calendar: Continuous deposits. Check with Bpifrance that your project meets the official DeepTech framework (readable on Bpifrance.fr).

For whom? Creative project leaders (technical feasibility established) or young companies less than 2 years old.

Amount: Up to €600,000 in grant (eligible expenses up to €1 million).

Scope: Personnel, R&D, prototyping, intellectual property, feasibility studies.

Plus: Beyond funding, being an i-Lab winner is a huge guarantee of credibility with VCs and private investors.

Deadline 2026: February 3, 2026 at 12 p.m. (exclusive submission on Picxel, Bpifrance platform).

Evaluation criteria: Technological innovation, economic viability, quality of the team, international development potential.

For whom? All companies (VSEs, SMEs, ETIs, large groups) carrying out research and development.

Amount: 30% of eligible R&D expenditure, up to 100 million euros annually (then 5% beyond).

What it covers: Researchers' salaries, R&D subcontracting to approved organizations, equipment depreciation, operating costs assessed at a flat rate.

Mechanical: The CIR reduces your corporate tax. If your credit exceeds your tax due, you can request an immediate refund (or postpone for 3 years).

News 2026: The rate remains 30% up to €100 million, with the possibility of rapid reimbursement for SMEs and young innovative companies.

Concrete example: An SME exposes €500,000 of eligible R&D expenses. She recovers €150,000 tax credit, i.e. a direct tax reduction of 30%.

For whom? SMEs and ETIs (less than 2,000 employees) with DeepTech projects with high technological risk.

Amount: Up to €2 million in mixed financing (grant + repayable advance).

Duration: Up to 36 months.

What it finances: Advanced R&D, prototypes, demonstrators, complex industrial tests before marketing.

Reimbursement of the advance: Quarterly, only in the event of commercial success of your product.

Difference with the Innovation Advance: The ADD specifically targets deeptech, while the Innovation Advance is more general and applies to any innovation project with high uncertainty.

For whom? Innovative SMEs and mid-sized companies, all sectors.

Amount: Up to €3M in reimbursable advance, up to 70% of expenses.

Reimbursement: Interest in the success of the project (quarterly in the event of turnover generated).

Advantage: No guarantee required, no strict financial covenants.

Key difference: Unlike a traditional bank loan, you only repay if the project generates turnover. If the innovation fails, the advance can become a subsidy.

For whom? SMEs and startups in France needing patents, trademarks, model designs.

Amount: Up to €5,000 (50% of eligible expenses, ceiling of €6,000 per service).

What it covers: Fees for industrial property advice (patent filings, drafting, IP strategy).

Please note: Up to 3 PI Passes per company during its development. Maximum cumulative amount: €10,000 excluding tax.

Condition: The service must be validated by the INPI before being carried out (no retroactive effect).

For whom? Companies created less than 8 years ago, making at least 20% of R&D expenses.

Tax benefits:

• ▸Exemption from employer social security contributions on the salaries of R&D staff (main cash flow lever).
• ▸Immediate reimbursement of CIR and CII (French innovation tax credit).
• ▸Exemption from CFE and TFPB for 7 years.

Please note (2026): JEIs created before 2024 still benefit from the income tax exemption. The JEIs created since 2024 no longer have it.

Amount of social exemption: Up to 100% of employer contributions for R&D staff (significant amount if you have a large team).

1. Submit a file after incurring expenses. Public grants require that the project not be committed at the time of submission. A simple signed order form can make your file inadmissible.

2. Ignore hidden eligibility criteria. Each aid has its pitfalls: maximum company size, excluded sector of activity, required location. Check the instructions before writing 20 pages.

3. Accumulating aid incorrectly. Double financing of the same expense is prohibited. If you receive an ADEME subsidy AND Bpifrance aid for the same project, declare it explicitly and justify the distribution.

4. Forgetting the justification for expenses. The tax services (for the CIR) or Bpifrance ask for detailed supporting documents. Invoices, timesheets, signed quotes: document everything in real time.

5. Underestimate administrative delays. Public aid is never instantaneous. Allow 1 to 3 months for a BFT, 4 to 6 months for i-Lab, 6 to 12 months for a lifting with Bpifrance guarantee. Plan ahead.

• ▸Continuous: BFT, BFTE, Avance Innovation, Add, CIR, Pass PI.
• ▸February 3, 2026 (12 p.m.): i-Lab Closing (Picxel).
• ▸September 30, 2026: CIR declaration (taxes).
• ▸December 2026: Closing of financial years (last chance to include your 2026 expenses in the CIR).

A good help request file includes:

1. ▸

   Clear presentation of the team: Who is leading the project? What skills? Why you rather than others?

2. ▸

   Technical description of the project: What is the technological barrier? What doesn't exist on the market?

3. ▸

   Detailed and justified budget: No “€50,000 for R&D”. Detail: X months of senior developer, Y months of engineer, Z hardware.

4. ▸

   Balanced financing plan: Aid never finances 100% of the project. Show your co-financing (equity, guaranteed bank loan).

5. ▸

   Realistic timeline: Clear technical milestones, measurable deliverables.

Hayot Expertise advice: At Hayot Expertise, we structure your financing files upstream. This includes checking eligibility, financial engineering to accumulate the right aid, and assisted writing. A good prepared file increases your chances by 40% on average. Contact us for a free eligibility audit.

The French State has clearly chosen to finance non-dilutive innovation: subsidies, repayable advances, tax credits. It's not charity, it's a strategy. It's up to you to take advantage of it intelligently.

The equation is simple: If you have a credible innovation, a complementary team, and a well-structured file, you can finance 40 to 60% of your R&D expenses without selling part of your company. The rest, you finance via a Bpifrance guaranteed bank loan, equity, or non-dilutive business angels.

The real question is not “Where to find money?” but “What combination of aid aligns with my project and my cash flow capacity?”

The best help is the one you apply for on time, with a solid file.

Ready to structure your financing strategy? At Hayot Expertise, we support SMEs and startups in optimizing their access to public aid 2026. Free eligibility audit, accumulation strategy, drafting of files: Contact our team for an initial discussion without obligation.